Article: Role of L-arginine in the pathogenesis and treatment of renal disease.
2003 Volume 134, Issue 10 Suppl, Page(s) 2801S–2806S; discussion 2818S–2819S
Abstract: L-arginine is a semi essential amino acid and also a substrate for the synthesis of nitric oxide (NO), polyamines, and agmatine. These L-arginine metabolites may participate in the pathogenesis of renal disease and constitute the rationale for ... ...
Abstract | L-arginine is a semi essential amino acid and also a substrate for the synthesis of nitric oxide (NO), polyamines, and agmatine. These L-arginine metabolites may participate in the pathogenesis of renal disease and constitute the rationale for manipulating L-arginine metabolism as a strategy to ameliorate kidney disease. Modification of dietary L-arginine intake in experimental models of kidney diseases has been shown to have both beneficial as well as deleterious effects depending on the specific model studied. L-arginine supplementation in animal models of glomerulonephritis has been shown to be detrimental, probably by increasing the production of NO from increased local expression of inducible NO synthase (iNOS). L-arginine supplementation does not modify the course of renal disease in humans with chronic glomerular diseases. However, beneficial effects of L-arginine supplementation have been reported in several models of chronic kidney disease including renal ablation, ureteral obstruction, nephropathy secondary to diabetes, and salt-sensitive hypertension. L-arginine is reduced in preeclampsia and recent experimental studies indicate that L-arginine supplementation may be beneficial in attenuating the symptoms of preeclampsia. Administration of exogenous L-arginine has been shown to be protective in ischemic acute renal failure. In summary, the role of L-arginine in the pathogenesis and treatment of renal disease is not completely understood and remains to be established. |
---|---|
MeSH term(s) | Acute Kidney Injury/drug therapy ; Animals ; Arginine/administration & dosage ; Arginine/adverse effects ; Arginine/therapeutic use ; Chronic Disease ; Diet ; Female ; Glomerulonephritis/physiopathology ; Humans ; Kidney Diseases/chemically induced ; Kidney Diseases/drug therapy ; Kidney Glomerulus/drug effects ; Pre-Eclampsia/drug therapy ; Pregnancy |
Chemical Substances | Arginine (94ZLA3W45F) |
Language | English |
Publishing date | 2003-05-14 |
Publishing country | United States |
Document type | Journal Article ; Research Support, U.S. Gov't, Non-P.H.S. ; Review |
ZDB-ID | 218373-0 |
ISSN | 1541-6100 ; 0022-3166 |
ISSN (online) | 1541-6100 |
ISSN | 0022-3166 |
DOI | 10.1093/jn/134.10.2801S |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uc I Zs.205: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.